PRF Technologies (PRFX) Share-based Compensation (2020 - 2022)
PRF Technologies (PRFX) recorded quarterly Share-based Compensation of $210000.0 in Q1 2022, up 28.05% on a QoQ basis from $164000.0 in Q1 2021, and up 28.05% year-over-year from $164000.0 in Q1 2021.
PRF Technologies (PRFX) Share-based Compensation (2020 - 2022) Analysis & Trends
PRF Technologies has disclosed Share-based Compensation across 3 years of filings, most recently posting $210000.0 for Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 36.86 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.04 Mn |
| 10 | PRF Technologies | 933,081.16 | -2.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 210,000.00 |
| Mar 31, 2022 | 210,000.00 |
| Mar 31, 2021 | 164,000.00 |
| Mar 31, 2021 | 164,000.00 |
| Mar 31, 2020 | 16,000.00 |
| Mar 31, 2020 | 16,000.00 |